Beli & Jual Suparma Tbk. - SPMA Hari Ini
Quarterly
Yearly
Income Statement
Revenue
Net Profit
Net Loss
Profit margin %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Revenue | Rp2,74 T | +0.41% |
| Cost of Revenue | Rp2,31 T | -0.45% |
| Gross Profit | Rp434,43 M | +5.23% |
| General Expenses, Depreciation, Interest | Rp230,65 M | +6.15% |
| Operating Profit | Rp203,78 M | +4.2% |
| Other Income | -Rp67,05 M | +9.7% |
| EBT | Rp136,74 M | +1.71% |
| Taxes | -Rp30,51 M | +3.05% |
| Net Income | Rp106,23 M | +1.33% |
Balance Sheet
Assets
Liabilities
Debt to Asset %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Total Assets | Rp3,66 T | +7.91% |
| Total Liabilities | Rp1,17 T | +16.23% |
| Total Equity | Rp2,49 T | +4.39% |
| Total Liabilities & Total Equity | Rp3,66 T | +7.91% |
Cash Flow
Operating
Investing
Finance
Net CF
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| CF from Operations | Rp583,29 M | -17.94% |
| CF from Investment | Rp61,15 M | +16.04% |
| CF from Financing | Rp603,76 M | -13.14% |
| Net Cash Flow | Rp81,62 M | +120.83% |